BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 11686101)

  • 1. Appropriate laboratory assessment as a critical facet in the proper diagnosis and classification of von Willebrand disorder.
    Favaloro EJ
    Best Pract Res Clin Haematol; 2001 Jun; 14(2):299-319. PubMed ID: 11686101
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Laboratory assessment as a critical component of the appropriate diagnosis and sub-classification of von Willebrand's disease.
    Favaloro EJ
    Blood Rev; 1999 Dec; 13(4):185-204. PubMed ID: 10741895
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Laboratory identification of von Willebrand disease: technical and scientific perspectives.
    Favaloro EJ
    Semin Thromb Hemost; 2006 Jul; 32(5):456-71. PubMed ID: 16862518
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Von Willebrand factor collagen-binding (activity) assay in the diagnosis of von Willebrand disease: a 15-year journey.
    Favaloro EJ
    Semin Thromb Hemost; 2002 Apr; 28(2):191-202. PubMed ID: 11992242
    [TBL] [Abstract][Full Text] [Related]  

  • 5. von Willebrand disease: a laboratory approach.
    Trasi S; Ghosh K; Shetty S; Mohanty D
    Natl Med J India; 2005; 18(2):78-84. PubMed ID: 15981443
    [TBL] [Abstract][Full Text] [Related]  

  • 6. von Willebrand disease in a pediatric-based population--comparison of type 1 diagnostic criteria and use of the PFA-100 and a von Willebrand factor/collagen-binding assay.
    Dean JA; Blanchette VS; Carcao MD; Stain AM; Sparling CR; Siekmann J; Turecek PL; Lillicrap D; Rand ML
    Thromb Haemost; 2000 Sep; 84(3):401-9. PubMed ID: 11019962
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Laboratory testing for von Willebrand disease: contribution of multimer analysis to diagnosis and classification.
    Budde U; Pieconka A; Will K; Schneppenheim R
    Semin Thromb Hemost; 2006 Jul; 32(5):514-21. PubMed ID: 16862525
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Laboratory monitoring of therapy in von Willebrand disease: efficacy of the PFA-100 and von Willebrand factor:collagen-binding activity as coupled strategies.
    Favaloro EJ
    Semin Thromb Hemost; 2006 Sep; 32(6):566-76. PubMed ID: 16977567
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnosis and classification of von Willebrand disease: a review of the differential utility of various functional von Willebrand factor assays.
    Favaloro EJ
    Blood Coagul Fibrinolysis; 2011 Oct; 22(7):553-64. PubMed ID: 21885953
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Laboratory testing for von Willebrand's disease: an assessment of current diagnostic practice and efficacy by means of a multi-laboratory survey. RCPA Quality Assurance Program (QAP) in Haematology Haemostasis Scientific Advisory Panel.
    Favaloro EJ; Smith J; Petinos P; Hertzberg M; Koutts J
    Thromb Haemost; 1999 Oct; 82(4):1276-82. PubMed ID: 10544913
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Laboratory diagnosis and molecular classification of von Willebrand disease.
    Gadisseur A; Hermans C; Berneman Z; Schroyens W; Deckmyn H; Michiels JJ
    Acta Haematol; 2009; 121(2-3):71-84. PubMed ID: 19506352
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Toward a new paradigm for the identification and functional characterization of von Willebrand disease.
    Favaloro EJ
    Semin Thromb Hemost; 2009 Feb; 35(1):60-75. PubMed ID: 19308894
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lower limit of assay sensitivity: an under-recognised and significant problem in von Willebrand disease identification and classification.
    Favaloro EJ; Bonar R; Marsden K
    Clin Lab Sci; 2008; 21(3):178-83. PubMed ID: 18678140
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Reliable von Willebrand factor: ristocetin cofactor enzyme-linked immunosorbent assay to differentiate between type 1 and type 2 von Willebrand disease.
    Vanhoorelbeke K; Cauwenberghs N; Vandecasteele G; Vauterin S; Deckmyn H
    Semin Thromb Hemost; 2002 Apr; 28(2):161-6. PubMed ID: 11992239
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Laboratory diagnosis of von Willebrand disorder: use of multiple functional assays reduces diagnostic error rates.
    Favaloro EJ; Bonar R; Kershaw G; Sioufi J; Thom J; Baker R; Hertzberg M; Street A; Lloyd J; Marsden K;
    Lab Hematol; 2005; 11(2):91-7. PubMed ID: 16024332
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Laboratory diagnosis of congenital von Willebrand disease.
    Budde U; Drewke E; Mainusch K; Schneppenheim R
    Semin Thromb Hemost; 2002 Apr; 28(2):173-90. PubMed ID: 11992241
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An update on the von Willebrand factor collagen binding assay: 21 years of age and beyond adolescence but not yet a mature adult.
    Favaloro EJ
    Semin Thromb Hemost; 2007 Nov; 33(8):727-44. PubMed ID: 18175279
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Prevalence, pathophysiology, diagnosis and treatment of von Willebrand syndrome in orthopedic trauma patients].
    Kurth AA; Ludwig G; Scharrer I
    Orthopade; 1999 Apr; 28(4):366-74. PubMed ID: 10335531
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative study on collagen-binding enzyme-linked immunosorbent assay and ristocetin cofactor activity assays for detection of functional activity of von Willebrand factor.
    Turecek PL; Siekmann J; Schwarz HP
    Semin Thromb Hemost; 2002 Apr; 28(2):149-60. PubMed ID: 11992238
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Classification of inherited von Willebrand disease and implications in clinical practice.
    Federici AB
    Thromb Res; 2009 Nov; 124 Suppl 1():S2-6. PubMed ID: 19944257
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.